Citation Impact
Citing Papers
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987
2012
The gut microbiota and host health: a new clinical frontier
2015 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Glutathione S-conjugates as prodrugs to target drug-resistant tumors
2014
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome
2012
Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status
2011
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
EVALUATION OF URINE N1,N12-DIACETYLSPERMINE AS POTENTIAL TUMOR MARKER FOR URINARY BLADDER CANCER
2006
Defining the role of NMP22 in bladder cancer surveillance
2007
Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis
2012
Contribution of platelets to tumour metastasis
2011 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Asymptomatic Nephrolithiasis Detected by Ultrasound
2009
Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors
2009
Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer
2009
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
CD44 and its partners in metastasis
2003
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
2012
Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance
2003
Human prostate cancer risk factors
2004
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Clinical Significance of Platelet Count in Patients with Renal Cell Carcinoma
2007
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Epidemiology of Prostate Cancer
2019 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study
2009
Cardiac Glycosides as Novel Cancer Therapeutic Agents
2008 Standout
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
Quality control in transurethral resection of bladder tumours
2008
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Predictive factors of recurrence and survival of upper tract urothelial carcinomas
2011
Analysis of the Na,K‐ATPase α‐ and β‐subunit expression profiles of bladder cancer using tissue microarrays
2003
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
History, epidemiology and regional diversities of urolithiasis
2008
Sexual dysfunction and infertility as late effects of cancer treatment
2014
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Cancer treatment and survivorship statistics, 2012
2012 Standout
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests
2002
The Schedule and Duration of Intravesical Chemotherapy in Patients with Non–Muscle-Invasive Bladder Cancer: A Systematic Review of the Published Results of Randomized Clinical Trials
2008
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines
2011
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy
2011
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Epidemiology of stone disease across the world
2017 Standout
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature
2013
Nrf2–Keap1 defines a physiologically important stress response mechanism
2004 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Renal cell carcinoma
2017 Standout
Independent predictors of cancer‐specific survival in transitional cell carcinoma of the upper urinary tract
2007
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma
2012
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
The Impact Factors on Prognosis of Patients With pT3 Upper Urinary Tract Transitional Cell Carcinoma
2007
An exploration of outcome criteria in nocturnal enuresis treatmentThe way forward
2004
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer
2011
Behavior of Urothelial Carcinoma With Respect to Anatomical Location
2007
Association of Tumor Necrosis With Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study
2010
Medical Management of Kidney Stones: AUA Guideline
2014 Standout
Reply to Anna Orsola, Lluís Cecchini and Juan Morote's Letter to the Editor re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303–14
2008
A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
2004
The Role of Tumor-Free Status in Repeat Resection Before Intravesical Bacillus Calmette-Guerin for High Grade Ta, T1 and CIS Bladder Cancer
2010
Management of Low Grade Papillary Bladder Tumors
2007
Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)
1989
Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma
2009
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma
2015
2014
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO
2002
Cancer treatment and survivorship statistics, 2019
2019 Standout
Long-Term Medical Care of Testicular Cancer Survivors
2002
Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer
2014
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
2012
CYSTINE CALCULI IN CHILDREN: THE RESULTS OF A METABOLIC EVALUATION AND RESPONSE TO MEDICAL THERAPY
2001
Fatigue, Anxiety, and Depression in Long-Term Survivors of Testicular Cancer
2003
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Preoperative Multivariable Prognostic Model for Prediction of Nonorgan Confined Urothelial Carcinoma of the Upper Urinary Tract
2010
The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society
2015 Standout
Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
2016
Template‐based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study
2013
The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Report from the Standardisation Committee of the International Children’s Continence Society
2006 Standout
A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
2011
Clinical Practice Recommendations for the Management of Non–Muscle Invasive Bladder Cancer
2008
Kidney stones: a global picture of prevalence, incidence, and associated risk factors.
2010 Standout
Works of Haluk Özen being referenced
Bladder cancer
2002
Bladder cancer
2000
CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population
2004
Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?
2012
Long-Term Treatnent of Nocturnal Enuresis withi Desmopressin Intranasal Spray
1997
Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
2005
Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells
2009
Glutathione S-transferase M1 gene polymorphism in bladder cancer patients
2001
Clinical significance of serum ferritin in patients with renal cell carcinoma
1995
Gynecomastia as a complication of chemotherapy for testicular germ cell tumors
1996
Prevalence and Predictors of Benign Lesions in Renal Masses Smaller Than 7 cm Presumed to be Renal Cell Carcinoma
2012
Repeated Transurethral Resection and Intravesical BCG for Extensive Superficial Bladder Tumors
2001
A STUDY OF THE ETIOLOGY OF IDIOPATHIC CALCIUM UROLITHIASIS IN CHILDREN: HYPOCITRURIA IS THE MOST IMPORTANT RISK FACTOR
2000
Prognostic factors in superficial bladder cancer
1986
The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
2006
PSYCHOSOCIAL ADJUSTMENT AFTER TESTICULAR CANCER TREATMENT
1998
Is a Second Transurethral Resection Necessary for Newly Diagnosed pT1 Bladder Cancer?
2006
Erectile dysfunction in successfully treated lymphoma patients
2007
Prognostic Significance of Bladder Tumor History and Tumor Location in Upper Tract Transitional Cell Carcinoma
2006
FALSE-POSITIVE RESULTS OF THE NMP22 TEST DUE TO HEMATURIA
2002
Determination of Prognosis in Patients With Prostate Cancer Treated With Radical Prostatectomy: Prognostic Value of CD44v6 Score
2002
Prospective Long-Term Followup of Patients With Asymptomatic Lower Pole Caliceal Stones
2007
The Predictive Value Of Purified Protein Derivative Results On Complications And Prognosis In Patients With Bladder Cancer Treated With Bacillus Calmette-Guerin
2003